ARCHIVES

Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 17 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

Senate Bill Would Require Clinical Trials To Test Gender, Racial Differences In Therapies

August 10, 1990

ASCO Guidelines On CSFs Call For Use In Fewer Patients

December 2, 1994

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

In Brief: Ira Kline, NCI researcher, Dead At 69; Massey Recruits Scientists; ACR Awards

October 15, 1993